These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30585401)

  • 21. New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry.
    Shan SW; Do CW; Lam TC; Kong RPW; Li KK; Chun KM; Stamer WD; To CH
    J Proteome Res; 2017 Oct; 16(10):3753-3765. PubMed ID: 28920441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.
    Kim YJ; Sertamo K; Pierrard MA; Mesmin C; Kim SY; Schlesser M; Berchem G; Domon B
    J Proteome Res; 2015 Mar; 14(3):1412-9. PubMed ID: 25597550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.
    Ma R; Xu H; Wu J; Sharma A; Bai S; Dun B; Jing C; Cao H; Wang Z; She JX; Feng J
    Oncotarget; 2017 Mar; 8(12):18901-18913. PubMed ID: 28121629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Multiple Reaction Monitoring and Sequential Window Acquisition of All Theoretical Mass Spectra for the Relative Quantification of Barley Gluten in Selectively Bred Barley Lines.
    Colgrave ML; Byrne K; Blundell M; Heidelberger S; Lane CS; Tanner GJ; Howitt CA
    Anal Chem; 2016 Sep; 88(18):9127-35. PubMed ID: 27533879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the Potential of Data-Independent Acquisition Proteomics Using Untargeted All-Ion Quantitation: Application to Tumor Subtype Diagnosis.
    Yan Z; Yan R
    Anal Chem; 2018 Apr; 90(7):4380-4388. PubMed ID: 29522333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
    Li QR; Liu YS; Zeng R
    Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes.
    Shi J; Wang X; Lyu L; Jiang H; Zhu HJ
    Drug Metab Pharmacokinet; 2018 Apr; 33(2):133-140. PubMed ID: 29610054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data-Independent Acquisition for the Quantification and Identification of Metabolites in Plasma.
    van der Laan T; Boom I; Maliepaard J; Dubbelman AC; Harms AC; Hankemeier T
    Metabolites; 2020 Dec; 10(12):. PubMed ID: 33353236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplex and Label-Free Relative Quantification Approach for Studying Protein Abundance of Drug Metabolizing Enzymes in Human Liver Microsomes Using SWATH-MS.
    Jamwal R; Barlock BJ; Adusumalli S; Ogasawara K; Simons BL; Akhlaghi F
    J Proteome Res; 2017 Nov; 16(11):4134-4143. PubMed ID: 28944677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-performance targeted mass spectrometry with precision data-independent acquisition reveals site-specific glycosylation macroheterogeneity.
    Yeo KYB; Chrysanthopoulos PK; Nouwens AS; Marcellin E; Schulz BL
    Anal Biochem; 2016 Oct; 510():106-113. PubMed ID: 27318240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive lipidomics of mouse plasma using class-specific surrogate calibrants and SWATH acquisition for large-scale lipid quantification in untargeted analysis.
    Drotleff B; Illison J; Schlotterbeck J; Lukowski R; Lämmerhofer M
    Anal Chim Acta; 2019 Dec; 1086():90-102. PubMed ID: 31561798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing SRM and SWATH Methods for Quantitation of Bovine Muscle Proteomes.
    Wu W; Dai RT; Bendixen E
    J Agric Food Chem; 2019 Feb; 67(5):1608-1618. PubMed ID: 30624930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.
    Djureinovic D; Pontén V; Landelius P; Al Sayegh S; Kappert K; Kamali-Moghaddam M; Micke P; Ståhle E
    BMC Cancer; 2019 Jul; 19(1):741. PubMed ID: 31357969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining label-free and label-based accurate quantifications with SWATH-MS: Comparison with SRM and PRM for the evaluation of bovine muscle type effects.
    Bons J; Husson G; Chion M; Bonnet M; Maumy-Bertrand M; Delalande F; Cianférani S; Bertrand F; Picard B; Carapito C
    Proteomics; 2021 May; 21(10):e2000214. PubMed ID: 33733615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SWATH-ID: An instrument method which combines identification and quantification in a single analysis.
    Kang Y; Burton L; Lau A; Tate S
    Proteomics; 2017 May; 17(10):e1500522. PubMed ID: 28387034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.
    Jin Y; Yang Y; Su Y; Ye X; Liu W; Yang Q; Wang J; Fu X; Gong Y; Sun H
    Glycoconj J; 2019 Feb; 36(1):57-68. PubMed ID: 30607521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
    Dittrich J; Ceglarek U
    Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.